NORDIC BIOSCIENCE CLINICAL STUDIES A/S: Financial statements 2012
CVR: 21144347
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
NORDIC BIOSCIENCE CLINICAL STUDIES A/S (CVR 21144347) has filed annual accounts for 2012. Equity in the 2012 report amounted to DKK 1,000,000.
- Equity
- DKK 1,000,000
Official annual report
Keep an eye on NORDIC BIOSCIENCE CLINICAL STUDIES A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout NORDIC BIOSCIENCE CLINICAL STUDIES A/S
NORDIC BIOSCIENCE CLINICAL STUDIES A/S was a Danish company of the type Aktieselskab based in Herlev, founded in 1998. The company has been dissolved on 26 November 2014. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company was previously named NORDIC BIOSCIENCE A/S and OSTEOPRO A/S. The company has 2 employees (2009). In 2013, the company reported a gross profit of DKK 52,902 and a net result of DKK -2,089,315. Equity in the 2013 report amounted to DKK -648,075.